The aim of the present study was to investigate the prevalence of the BRAF V600E mutation
in papillary thyroid carcinoma (PTC) and to determine the correlation between this mutation …

Abstract Background The BRAF V600E mutation is the most common genetic alteration in
papillary thyroid carcinoma (PTC). In recent studies, the BRAF V600E mutation has been …

Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …

Background. The BRAF V600E mutation is an important genetic event in papillary thyroid
cancer (PTC). This study aimed to provide additional information regarding the association …

It has been shown that BRAF V600E mutation in papillary thyroid carcinomas (PTC) is
associated both with pathogenesis and poor prognosis. In this study, we aimed to …

Purpose To investigate the prognostic value of BRAF V600E mutation for the recurrence of
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …

BACKGROUND: The effects of the BRAFV600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …

BACKGROUND. Numerous studies have investigated the clinical significance of BRAF
mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on …

Introduction: There have been contradictory data on whether or not BRAF V600E mutation
should be regard as a poor prognosis predictor of papillary thyroid carcinoma (PTC). To …

Background: Activating mutations of the BRAF gene have recently been reported in thyroid
carcinomas. In particular, V600E mutation is highly prevalent in papillary thyroid carcinoma …